Rampart Bioscience
NEWS
Rampart Bioscience was working on a platform to deliver gene therapies without the need for viral vectors.
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
IN THE PRESS
JOBS